Princeton Alpha Management’s Edwards Lifesciences EW Stock Holding History

Princeton Alpha Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-23,517	Closed	-$737K	–	122
2017 Q1	$737K	Sell	23,517 -12,891	-35%	-$404K	0.25%	122
2016 Q4	$1.14M	Buy	36,408 +7,977	+28%	+$258K	0.23%	117
2016 Q3	$1.14M	Sell	28,431 -41,832	-60%	-$1.58M	0.21%	135
2016 Q2	$2.34M	Buy	70,263 +60,153	+595%	+$2.06M	0.42%	38
2016 Q1	$297K	Sell	10,110 -70,560	-87%	-$1.95M	0.05%	527
2015 Q4	$2.12M	Buy	+80,670	New	+$2.09M	0.37%	61
2015 Q2	–	Sell	-28,854	Closed	-$685K	–	760
2015 Q1	$685K	Sell	28,854 -12,516	-30%	-$281K	0.15%	194
2014 Q4	$878K	Buy	+41,370	New	+$831K	0.25%	102
2014 Q3	–	Sell	-92,256	Closed	-$1.32M	–	709
2014 Q2	$1.32M	Buy	+92,256	New	+$1.25M	0.27%	93

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Princeton Alpha Management's EW Position: Q2 2017 in Review

Princeton Alpha Management sold out of Edwards Lifesciences (EW) in Q2 2017, closing a stake of 23,517 shares — an estimated $737K sold.

Princeton Alpha Management first reported a position in EW in Q2 2014 and held it in 9 quarters. The position peaked at $2.34M in Q2 2016. 720 funds tracked by Wall St. Rank hold EW as of Q2 2017.

Princeton Alpha Management reported no remaining Edwards Lifesciences position as of Q2 2017 after selling out during the quarter.
Princeton Alpha Management sold 23,517 Edwards Lifesciences shares in Q2 2017, an estimated $737K.
Princeton Alpha Management first reported a position in Edwards Lifesciences in Q2 2014 and held it in 9 quarters.
Princeton Alpha Management's Edwards Lifesciences position peaked at $2.34M in Q2 2016.
720 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.